Caricamento...
Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model
PURPOSE: Hyperuricemia is an independent risk factor for renal damage and can promote the progression of chronic kidney disease (CKD). In the present study, we employ a rat model to investigate the effects of rosiglitazone (RGTZ), a peroxisome proliferator-activated receptor-gamma agonist, on the de...
Salvato in:
| Pubblicato in: | Drug Des Devel Ther |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292262/ https://ncbi.nlm.nih.gov/pubmed/32606592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S247091 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|